AKT1 and atherosclerosis: The results showed that pathway in cancer, the P13K-Akt signaling pathway, the MAPK signaling pathway, the lipid and atheromatocellular cirrhosis pathway, and the atherosclerosis pathway were the main pathways for the prevention and treatment of irritable bowel syndrome.